Evinacumab Cuts LDL-C in Children With Homozygous Familial Hypercholesterolemia
Evinacumab is a fully-human monoclonal antibody that binds to and blocks the function of angiopoietin-like 3
Pediatrics
What Fish Is Best to Eat During Pregnancy?
The FDA and EPA have issued advice on how much and what kind of fish to eat when pregnant or breastfeeding and in children.
Antibody Response in Breast Milk After mRNA- vs Vector-Based COVID-19 Vaccination
Researchers compared the antibody response in human milk among women who received COVID-19 mRNA-based vaccines vs vector-based vaccines.
Pfizer-BioNTech COVID-19 Vaccine Booster Dose Authorized for 5- to 11-Year-Olds
The Pfizer-BioNTech COVID-19 vaccine can be administered as a single booster dose to individuals 5 to 11 years of age at least 5 months after completion of the primary series.
Adjuvanted Enterovirus 71 Vaccine Is Highly Effective in Infants and Children
Researchers assessed the efficacy of an adjuvanted enterovirus 71 (EV71) vaccine for the prevention of EV71-associated infections among infants and children.
Screening Tool Combats Food Insecurity and Pediatric Obesity
The aim of the study was to identify individuals with food insecurity and establish processes to refer patients and families to federal and community resources.
Nonstimulant ADHD Treatment Option Approved for Adults
The approval was based on data from a phase 3 trial that assessed Qelbree in adults 18 to 65 years of age with ADHD.
ATS Guideline: Outpatient Management of Pediatric Post-Prematurity Respiratory Disease
How should clinicians handle the outpatient management of infants, children, and adolescents with post-prematurity respiratory disease? A summary of updated recommendations from the American Thoracic Society offers guidance.
A Perfect Storm: Rise in Eating Disorders Among Teens During COVID-19
Eating disorders among adolescents have doubled since the start of the pandemic and patients are presenting with more severe symptoms.
Cabenuva Approval Expanded to Include Adolescents With HIV
The expanded approval was supported by data from studies in the adult population and by data from an interim analysis of the phase 1/2 MOCHA study.
- Loading...
Loading...
Next post in News
Loading... 
Loading...